Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEGLUMINE vs MELOXICAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEGLUMINE vs MELOXICAM: Safety Overview

Metric MEGLUMINE MELOXICAM
Total FAERS Reports 585 8,661
Deaths Reported 512 1,042
Death Rate 87.5% 12.0%
Hospitalizations 517 2,502
Average Patient Age 42.0 yrs 57.6 yrs
% Female Patients 96.1% 72.7%
FDA Approval Date N/A Apr 13, 2000
Manufacturer N/A Exelan Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Discontinued